Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Non-Invasive Approaches for Screening, Diagnosis, and Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Bariatric Patients & Identifying Biomarkers for Predicting Type 2 Diabetes Remission

NCT07172997 is registered in ClinicalTrials.gov with Royal College of Surgeons in Ireland - Medical University of Bahrain as lead sponsor.

NCT NCT07172997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07172997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Non-Invasive Approaches for Screening, Diagnosis, and Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Bariatric Patients & Identifying Biomarkers for Predicting Type 2 Diabetes Remission
Lead sponsor
Royal College of Surgeons in Ireland - Medical University of Bahrain
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2025
Completion date
June 30, 2027
Enrollment
163 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

masld, non-alcoholic fatty liver disease (nafld), obesity, t2dm (type 2 diabetes mellitus)